Amsbio expands biotechnology portfolio

Wnt Signaling Pathway products and other lines grow

Amsbio, the biotechnology company based in Abingdon, UK, is expanding its product lines within Wingless/Integrated (Wnt) recombinant proteins, stable reporter cell lines, antibodies and ELISA kits.

The lines have been expanded to include features for researchers in fields of development biology and oncology and the company highlights the new stabilisers in the recombinant proteins to prolong activity.

Amsbio produces products for the medical, nutrition, cosmetics and energy industries and works with many clients to develop and produce expand their number of products and services.